ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $303,901 | -17.5% | 16,921 | 0.0% | 0.00% | – |
Q2 2023 | $368,201 | 0.0% | 16,921 | 0.0% | 0.00% | – |
Q1 2023 | $368,201 | -99.9% | 16,921 | -26.5% | 0.00% | – |
Q3 2022 | $586,908,000 | +97.4% | 23,007 | +57.1% | 0.00% | – |
Q2 2022 | $297,314,000 | -47.8% | 14,646 | -36.3% | 0.00% | – |
Q1 2022 | $569,193,000 | -28.8% | 23,007 | 0.0% | 0.00% | – |
Q4 2021 | $799,494,000 | +21.2% | 23,007 | -5.4% | 0.00% | – |
Q3 2021 | $659,395,000 | +4.6% | 24,314 | 0.0% | 0.00% | – |
Q2 2021 | $630,462,000 | +99.8% | 24,314 | +66.0% | 0.00% | – |
Q1 2021 | $315,621,000 | -13.0% | 14,646 | -13.2% | 0.00% | – |
Q4 2020 | $362,771,000 | +45.8% | 16,873 | 0.0% | 0.00% | – |
Q3 2020 | $248,876,000 | -34.0% | 16,873 | 0.0% | 0.00% | – |
Q2 2020 | $376,943,000 | +85.9% | 16,873 | +17.6% | 0.00% | – |
Q1 2020 | $202,751,000 | -94.2% | 14,349 | -85.6% | 0.00% | -100.0% |
Q3 2019 | $3,482,135,000 | -39.5% | 99,518 | -2.5% | 0.00% | -50.0% |
Q2 2019 | $5,756,759,000 | -19.5% | 102,034 | +4.3% | 0.00% | -20.0% |
Q1 2019 | $7,149,402,000 | +19.3% | 97,870 | +4.2% | 0.01% | 0.0% |
Q4 2018 | $5,992,114,000 | -42.1% | 93,935 | -9.5% | 0.01% | -37.5% |
Q3 2018 | $10,350,937,000 | +55.6% | 103,748 | +10.8% | 0.01% | +60.0% |
Q2 2018 | $6,652,896,000 | -10.5% | 93,650 | +31.1% | 0.01% | -16.7% |
Q1 2018 | $7,437,244,000 | +3.5% | 71,457 | +0.1% | 0.01% | 0.0% |
Q4 2017 | $7,188,790,000 | – | 71,374 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |